Provided by Tiger Fintech (Singapore) Pte. Ltd.

Meiragtx Holdings Plc

7.79
-0.4600-5.58%
Post-market: 7.790.00000.00%19:40 EDT
Volume:1.51M
Turnover:12.20M
Market Cap:608.81M
PE:-5.80
High:8.75
Open:8.56
Low:7.70
Close:8.25
Loading ...

MeiraGTx price target raised to $14 from $12 at BofA

TIPRANKS
·
Yesterday

MeiraGTx Holdings Faces Financial Uncertainty Over Priority Review Vouchers for Gene Therapy

TIPRANKS
·
Yesterday

MeiraGTx Shares Soar After Joint Venture Deal With Hologen

MT Newswires Live
·
Yesterday

MeiraGTx Up Over 24%, On Track for Highest Close Since June 2023 -- Data Talk

Dow Jones
·
Yesterday

Crude Oil Falls 1%; Dollar General Posts Upbeat Sales

Benzinga
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx

Reuters
·
13 Mar

BUZZ-MeiraGTx rises on collaboration with Hologen to develop Parkinson's disease therapy

Reuters
·
13 Mar

MeiraGTx Holdings PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Mar

MeiraGTx Shares Rise on Collaboration with Hologen

Dow Jones
·
13 Mar

MeiraGTx Hldgs FY 2024 GAAP EPS $(2.12) Misses $(1.89) Estimate

Benzinga
·
13 Mar

BRIEF-MeiraGTx FY EPS USD -2.12

Reuters
·
13 Mar

MeiraGTx FY EPS USD -2.12

THOMSON REUTERS
·
13 Mar

Press Release: MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates

Dow Jones
·
13 Mar

BRIEF-MeiraGTx collaborates with Hologen AI to expedite development of its Parkison's disease therapy, scale up manufacturing

Reuters
·
13 Mar

MeiraGTx Holdings Plc - to Receive $200 Million in Upfront Cash

THOMSON REUTERS
·
13 Mar

MeiraGTx Enters Into a Strategic Collaboration With Hologen AI to Expedite Phase 3 Development of Aav-Gad for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process

THOMSON REUTERS
·
13 Mar